Morgan Rae Farber, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 720 Main St, Hoxie, KS 67740 Phone: 785-677-3777 Fax: 318-708-2801 |
News Archive
News outlets offer scene setters exploring the dynamics at play at the high court and the importance of the pending ruling on the constitutionality of the health law. They also look at how the decision will impact different parts of the health care sector, ranging from safety-net providers and investors to patient safety advocates and employers.
Rep. Michele Bachmann, R-Minn., is asking for a federal audit of her state's Medicaid program after a congressional probe found a year's worth of alleged overpayments. In other news, insurers Molina and Centene have won back Medicaid contracts in Ohio after initially being rejected.
It is great news for New York's health that state leaders are planning to increase the state cigarette tax by $1.60 per pack, while also increasing the tax on other tobacco products and ensuring that taxes are properly paid on cigarettes sold by Native American tribes to non-tribal members. Increasing the tobacco tax is one of the most effective ways to reduce smoking and other tobacco use, especially among children.
Bioengineers from the University of California, San Diego developed an explanation for why some types of neurons die sooner than others in the brains of people with Alzheimer's disease. These insights, published in the journal Nature Biotechnology on November 21, come from detailed models of brain energy metabolism developed in the Department of Bioengineering at the UC San Diego Jacobs School of Engineering.
Horizon Technology Finance Corporation ("Horizon"), a leading specialty finance company that provides secured loans to venture capital and private equity backed development-stage companies in the technology, life science, healthcare information and services, and clean-tech industries, today announced it has closed a $2 million venture loan facility with New Haven Pharmaceuticals, Inc. ("NHP"), a developer of prescription pharmaceuticals that utilize currently marketed drugs or active pharmaceutical ingredients generally recognized as safe for use in therapeutic applications.
› Verified 8 days ago